Evaluation of cell collection efficiency in non‐mobilized adult donors for autologous chimeric antigen receptor T‐cell manufacturing

Background and Objectives Data about collection efficiency 1 (CE1), which takes into account blood cell counts before and after collection, thus providing a more accurate estimate, in the collection of autologous T lymphocytes by apheresis for chimeric antigen receptor (CAR) T‐cells remain scarce. W...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vox sanguinis 2023-03, Vol.118 (3), p.217-222
Hauptverfasser: Piñeyroa, Juan A., Cid, Joan, Vlagea, Alexandru, Carbassé, Gloria, Henao, Paola, Bailo, Noemí, Ortiz‐Maldonado, Valentín, Martínez‐Cibrian, Núria, Español, Marta, Delgado, Julio, Urbano‐Ispizua, Álvaro, Lozano, Miquel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Objectives Data about collection efficiency 1 (CE1), which takes into account blood cell counts before and after collection, thus providing a more accurate estimate, in the collection of autologous T lymphocytes by apheresis for chimeric antigen receptor (CAR) T‐cells remain scarce. We evaluated donor‐ and procedure‐related characteristics that might influence the CE1 of lymphocytes. Materials and Methods We retrospectively reviewed all mononuclear cell (MNC) collections) performed for CAR T‐cell manufacturing in our institution from May 2017 to June 2021 in adult patients. Age, gender, weight, total blood volume (TBV), prior haematopoietic cell transplant, diagnosis, days between last treatment and apheresis, pre‐collection cell counts, duration of apheresis, TBV processed, vascular access, inlet flow and device type were analysed as potential factors affecting CE1 of lymphocytes. Results A total of 127 autologous MNC collections were performed on 118 patients diagnosed with acute lymphoblastic leukaemia (n = 53, 45%), non‐Hodgkin lymphoma (n = 40, 34%), multiple myeloma (n = 19, 16%), and chronic lymphocytic leukaemia (n = 6, 5%). The median CE1 of lymphocytes was 47% (interquartile range: 32%–65%). In multiple regression analysis, Amicus device was associated with higher CE1 of lymphocytes (p = 0.01) and lower CE1 of platelets (p 
ISSN:0042-9007
1423-0410
DOI:10.1111/vox.13394